UnitedHealth (UNH) shares fell 5% on July 29 due to increased medical costs impacting earnings for 2025, now projected at $16 per share, below analysts’ $20.91 estimate. Stock is down 55% from its year-to-date high. UNH aims to address challenges but expects medical costs to remain high at 89-89.5%. DOJ is investigating Medicare billing practices. Despite challenges, UNH remains a key U.S. health insurer trading at a low multiple. Shares have a P/S ratio of 0.64x and reported better-than-expected revenue in Q2 with a 3.3% dividend yield. Wall Street analysts maintain a “Moderate Buy” rating on UNH with a target price over 30% higher than current levels.

Read more at Yahoo Finance: Earnings Will Be ‘Worse Than Expected’ for UnitedHealth. How Should You Play UNH Stock Here?